ZYGLPIA
LIVE

Serial Number

97452965

Owner

Zydus Pharmaceuticals (USA) Inc.

Attorney

Anthony J. DiMarino

Filing Date

Jun 10, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ZYGLPIA Trademark

Serial Number: 97452965

ZYGLPIA is a trademark filed by Zydus Pharmaceuticals (USA) Inc. on June 10, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Zydus Pharmaceuticals (USA) Inc. (21 trademarks)

Suite 204
Princeton, NJ 08543

Entity Type: 03

Trademark Details

Filing Date

June 10, 2022

Registration Date

Not Registered

Published for Opposition

April 4, 2023

Goods & Services

Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment and prevention of eye diseases and conditions; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of hypertension; Pharmaceutical preparations for the treatment and prevention of skin disorders; Pharmaceutical preparations for the treatment and prevention of cancer and tumors; Pharmaceutical preparations for the treatment and prevention of allergies; Pharmaceutical preparations for the treatment and prevention of bone diseases; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and asthma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2026 EXRA
SOU EXTENSION 5 GRANTED
Apr 2, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 2, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Oct 24, 2025 EEXT
SOU EXTENSION 5 FILED
Oct 23, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2025 EXRA
SOU EXTENSION 4 GRANTED
Apr 21, 2025 EX4G
SOU EXTENSION 4 FILED
Apr 21, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 21, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 28, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 28, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 28, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2024 EXRA
SOU EXTENSION 2 GRANTED
Apr 16, 2024 EX2G
SOU EXTENSION 2 FILED
Apr 16, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 16, 2024 EEXT
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 11, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 11, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 11, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 11, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 19, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 19, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 19, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 30, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 4, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 4, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 16, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 16, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 16, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 16, 2023 CNEA
ASSIGNED TO EXAMINER
Feb 15, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 14, 2022 NWOS
NEW APPLICATION ENTERED
Jun 14, 2022 NWAP